Individual-level attribution modeling reveals that real-world semaglutide effectiveness is not a fixed property of the molecule, but an interaction between pharmacological exposure and modifiable care ...

Myers' upcoming $30B patent cliff as the Growth portfolio lost significant potential. Read why BMY stock is downgraded to ...

Neurocrine Biosciences, Inc. ( NBIX) Q4 2025 Earnings Call February 11, 2026 4:30 PM EST ...

Anson Resources has produced high-purity lithium carbonate suitable for EV batteries at its Green River brine project in Utah ...

Ferric citrate significantly improves hemoglobin levels and is well tolerated in patients with NDD CKD and iron deficiency anemia.

With data from a mid-stage trial showing weight loss of up to 12.3% at 28 weeks in patients treated with PF’3944, "Pfizer is moving full speed into obesity clinical development,” BMO Capital Markets ...

Explore how ABB Robotics is reshaping laboratory automation with AI and collaborative robotics at SLAS 2026 in Boston.

Pfizer closed the fourth quarter with revenue ahead of Wall Street expectations, but the market reacted negatively due to a combination of year-over-year sales decline and shrinking operating margins.

Detailed price information for Eranova Metals Inc (NOVA-X) from The Globe and Mail including charting and trades.

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

Detailed price information for Honey Badger Silver Inc (TUF-X) from The Globe and Mail including charting and trades.

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?